1. Academic Validation
  2. Identification of the monomeric G-protein, Rhes, as an efaroxan-regulated protein in the pancreatic beta-cell

Identification of the monomeric G-protein, Rhes, as an efaroxan-regulated protein in the pancreatic beta-cell

  • Br J Pharmacol. 2002 May;136(1):31-6. doi: 10.1038/sj.bjp.0704680.
Sue L F Chan 1 Lara K Monks Hongwei Gao Pamela Deaville Noel G Morgan
Affiliations

Affiliation

  • 1 Institute of Cell Signalling, University of Nottingham, Queen's Medical Centre, Nottingham NG7 2UH, UK.
Abstract

Efaroxan induces membrane depolarization by interaction with the pore forming subunit of the ATP-sensitive Potassium Channel, Kir6.2. However, this effect is not responsible for its full secretory activity. In this study we have used an anti-idiotypic approach to generate Antibodies that recognize additional proteins that may be regulated by efaroxan in pancreatic beta-cells. Using these antisera in an expression cloning strategy we have identified a monomeric GTP-binding protein, Rhes, as a potential target for regulation by imidazoline ligands. Rhes is shown to be expressed in beta-cells and its expression is regulated by efaroxan under conditions when a structurally related molecule, KU14R, is ineffective. The results reveal that beta-cells express Rhes and suggest that changes in the expression of this molecule may regulate the sensitivity of beta-cells to imidazoline secretagogues.

Figures